Literature DB >> 87297

[Serologic breast cancer follow-up monitoring using pregnancy-associated alpha-2-glycoproteins].

H W Bauer, I Hasselblatt, K J Husfeldt, H Bohn.   

Abstract

The variations in serum level of the alpha 2-PAG (pregnancy associated glycoprotein) were studied during the treatment of 25 patients with breast cancer. A good correlation was found between alpha 2-PAG concentration and the course of the disease. Serum alpha 2-Pag levels rose prior to the clinical recognition of metastatic disease and decreased significantly on successful treatment. alpha 2-PAG appears to have potential as an indicator of the growth of micrometastases.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 87297

Source DB:  PubMed          Journal:  Chir Forum Exp Klin Forsch        ISSN： 0303-6227


  3 in total

Review 1.  [Pregnancy-specific and pregnancy-associated proteins for diagnosing and monitoring malignant disease (author's transl)].

Authors:  H W Bauer; H Bohn
Journal:  Klin Wochenschr       Date:  1978-06-01

2.  Pregnancy specific beta 1-glycoprotein and alpha 2-pregnancy associated globulin in tumours of the female genital tract.

Authors:  H Ludwig; G Tatra
Journal:  Klin Wochenschr       Date:  1981-07-15

Review 3.  The pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG). A tumour marker?

Authors:  H W Bauer
Journal:  Klin Wochenschr       Date:  1981-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.